{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:03:23Z","timestamp":1778259803045,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["G2023129019L"],"award-info":[{"award-number":["G2023129019L"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009991","name":"Jilin Province Department of Finance","doi-asserted-by":"publisher","award":["JLSWSRCZX2023-8"],"award-info":[{"award-number":["JLSWSRCZX2023-8"]}],"id":[{"id":"10.13039\/501100009991","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.omtn.2024.102346","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T20:56:43Z","timestamp":1727384203000},"page":"102346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["HBx induces chemoresistance in diffuse large B cell lymphoma by inhibiting intrinsic apoptosis via the NF-\u03baB\/XIAP pathway"],"prefix":"10.1016","volume":"35","author":[{"given":"Zhumei","family":"Zhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4066-9473","authenticated-orcid":false,"given":"Ou","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2024.102346_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061358","article-title":"Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review","volume":"20","author":"Kanda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2024.102346_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9151-4_1","article-title":"Hepatitis B Virus Infection: Overview","volume":"1179","author":"Li","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtn.2024.102346_bib3","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/jmv.25653","article-title":"Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a national sample cohort","volume":"92","author":"Kim","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.omtn.2024.102346_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193232","article-title":"Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study","volume":"13","author":"An","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102346_bib5","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/cncr.22549","article-title":"High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers","volume":"109","author":"Wang","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12885-019-5718-x","article-title":"Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1324113","article-title":"Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP","volume":"15","author":"Zhan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtn.2024.102346_bib8","first-page":"256","article-title":"The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections","volume":"4","author":"Bumbea","year":"2011","journal-title":"J.\u00a0Med. Life"},{"key":"10.1016\/j.omtn.2024.102346_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/etm.2013.1079","article-title":"Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy","volume":"6","author":"Xie","year":"2013","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omtn.2024.102346_bib10","doi-asserted-by":"crossref","first-page":"25061","DOI":"10.18632\/oncotarget.4677","article-title":"Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin","volume":"6","author":"Deng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtn.2024.102346_bib11","doi-asserted-by":"crossref","first-page":"7680","DOI":"10.1038\/sj.onc.1209753","article-title":"Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2024.102346_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hon.774","article-title":"Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B-cell lymphoma","volume":"24","author":"Muris","year":"2006","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.omtn.2024.102346_bib13","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2147\/OTT.S33375","article-title":"IAP proteins as targets for drug development in oncology","volume":"9","author":"Dubrez","year":"2013","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.omtn.2024.102346_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111493","article-title":"XIAP's Profile in Human Cancer","volume":"10","author":"Tu","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.omtn.2024.102346_bib15","article-title":"Hepatitis B virus infection","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.omtn.2024.102346_bib16","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.7150\/jca.24384","article-title":"Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma","volume":"9","author":"Wang","year":"2018","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jvh.13301","article-title":"Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma","volume":"27","author":"Huang","year":"2020","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.omtn.2024.102346_bib18","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1016\/j.ymthe.2021.04.011","article-title":"TRERNA1 upregulation mediated by HBx promotes sorafenib resistance and cell proliferation in HCC via targeting NRAS by sponging miR-22-3p","volume":"29","author":"Song","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2024.102346_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092210","article-title":"Hepatitis B x (HBx) as a Component of a Functional Cure for Chronic Hepatitis B","volume":"10","author":"Feitelson","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.omtn.2024.102346_bib20","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1111\/j.1365-2893.2011.01463.x","article-title":"Involvement of the NF-\u03baB pathway in multidrug resistance induced by HBx in a hepatoma cell line","volume":"18","author":"Liu","year":"2011","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.omtn.2024.102346_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5483\/BMBRep.2019.52.5.312","article-title":"C-terminal truncated HBx reduces doxorubicin cytotoxicity via ABCB1 upregulation in Huh-7 hepatocellular carcinoma cells","volume":"52","author":"Jegal","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.omtn.2024.102346_bib22","first-page":"2043","article-title":"Hepatitis B virus upregulates cellular inhibitor of apoptosis protein 2 expression via the PI3K\/AKT\/NF-\u03baB signaling pathway in liver cancer","volume":"19","author":"Lian","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omtn.2024.102346_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/jmv.20466","article-title":"Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues","volume":"77","author":"Zhang","year":"2005","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.omtn.2024.102346_bib24","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1158\/1078-0432.CCR-03-0574","article-title":"Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma","volume":"10","author":"Chan","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2024.102346_bib25","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.0507809103","article-title":"The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas","volume":"103","author":"Bernal-Mizrachi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2024.102346_bib26","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","article-title":"A Review on Caspases: Key Regulators of Biological Activities and Apoptosis","volume":"60","author":"Sahoo","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.omtn.2024.102346_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174363","article-title":"Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance","volume":"13","author":"Neophytou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omtn.2024.102346_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13046-022-02531-x","article-title":"Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-\u03baBp65\/HK2 signalling","volume":"41","author":"Chen","year":"2022","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omtn.2024.102346_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virusres.2011.01.001","article-title":"The X protein of HBV induces HIV-1 long terminal repeat transcription by enhancing the binding of C\/EBP\u03b2 and CREB1\/2 regulatory proteins to the long terminal repeat of HIV-1","volume":"156","author":"Mu","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.omtn.2024.102346_bib30","doi-asserted-by":"crossref","first-page":"10732","DOI":"10.3748\/wjg.v21.i38.10732","article-title":"Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis","volume":"21","author":"Geng","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.omtn.2024.102346_bib31","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/nar\/gkac070","article-title":"High mobility group AT-hook 1 (HMGA1) is an important positive regulator of hepatitis B virus (HBV) that is reciprocally upregulated by HBV X protein","volume":"50","author":"Shen","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2024.102346_bib32","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/ijc.33027","article-title":"Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma","volume":"147","author":"Li","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00277-017-3188-2","article-title":"High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China","volume":"97","author":"Wang","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.omtn.2024.102346_bib34","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.7150\/jca.31033","article-title":"Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review","volume":"10","author":"Rong","year":"2019","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1634\/theoncologist.2019-0756","article-title":"Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era","volume":"25","author":"Cheng","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.omtn.2024.102346_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12032-014-0845-3","article-title":"HBsAg is an independent prognostic factor in diffuse large B cell lymphoma patients in rituximab era: result from a multicenter retrospective analysis in China","volume":"31","author":"Wei","year":"2014","journal-title":"Med. Oncol."},{"key":"10.1016\/j.omtn.2024.102346_bib37","article-title":"Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP\/CHOP-Like Chemotherapy","volume":"10","author":"Guo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2024.102346_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41419-017-0097-1","article-title":"HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omtn.2024.102346_bib39","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.omtn.2022.01.015","article-title":"lncNBAT1\/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. Molecular therapy","volume":"27","author":"Li","year":"2022","journal-title":"Mol Ther Nucleic Acids."},{"key":"10.1016\/j.omtn.2024.102346_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/aps.2009.99","article-title":"Transformation of human liver L-O2 cells mediated by stable HBx transfection","volume":"30","author":"Zhang","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.omtn.2024.102346_bib41","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/ijc.28501","article-title":"Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression","volume":"134","author":"Wu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtn.2024.102346_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036426","article-title":"Regulation of Cell Death and Immunity by XIAP","volume":"12","author":"Jost","year":"2020","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.omtn.2024.102346_bib43","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10495-022-01734-z","article-title":"XIAP as a multifaceted molecule in Cellular Signaling","volume":"27","author":"Hanifeh","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.omtn.2024.102346_bib44","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1172\/JCI200422222","article-title":"Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis","volume":"114","author":"Dohi","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2024.102346_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1182\/blood-2007-04-085480","article-title":"Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cells","volume":"111","author":"Cillessen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2024.102346_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1099\/0022-1317-82-4-871","article-title":"Intracellular localization of the hepatitis B virus HBx protein","volume":"82","author":"Henkler","year":"2001","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omtn.2024.102346_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3892\/ijmm.2016.2637","article-title":"Hepatitis B virus X protein promotes renal epithelial-mesenchymal transition in human renal proximal tubule epithelial cells through the activation of NF-\u03baB","volume":"38","author":"Li","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.omtn.2024.102346_bib48","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2010.02.016","article-title":"HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways","volume":"397","author":"Kim","year":"2010","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.omtn.2024.102346_bib49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00535-013-0848-4","article-title":"BAY 11-7082, a nuclear factor-\u03baB inhibitor, induces apoptosis and S phase arrest in gastric cancer cells","volume":"49","author":"Chen","year":"2014","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.omtn.2024.102346_bib50","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1182\/blood-2014-09-603555","article-title":"Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML","volume":"125","author":"Rijal","year":"2015","journal-title":"Blood"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124002336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253124002336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:16:51Z","timestamp":1764177411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253124002336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2162253124002336"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102346","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBx induces chemoresistance in diffuse large B cell lymphoma by inhibiting intrinsic apoptosis via the NF-\u03baB\/XIAP pathway","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2024.102346","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102346"}}